dendreon corp (DNDNQ:OTC US)
Former Vice President of Corporate Communications and Vice President of Investor Relations, Dendreon Corp.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Ms. Katherine Stueland served as an Associate of WeissComm Partners, Inc. Ms. Stueland served as Vice President of Corporate Communications and Investor Relations at Dendreon Corp. Ms. Stueland joined WeissComm from TAP Pharmaceutical Products Inc., where she served as the Head of Public Affairs and was responsible for providing strategic counsel to the executive leadership team and managing product and marketing public relations for Prevacid for acid reflux and Lupron ...
1301 2nd AvenuePhone: 206-256-4545
Seattle, Washington 98101
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Peter D. Meldrum Ph.D.||Chief Executive Officer, President and Director|
Myriad Genetics Inc.
|Stephen H. Rusckowski||Chief Executive Officer, President and Director|
Quest Diagnostics Inc.
|$1.1M||Compensation as of Fiscal Year 2014.|